251 related articles for article (PubMed ID: 30924937)
1. Impact of SBRT fractionation in hypoxia dose painting - Accounting for heterogeneous and dynamic tumor oxygenation.
Kjellsson Lindblom E; Ureba A; Dasu A; Wersäll P; Even AJG; van Elmpt W; Lambin P; Toma-Dasu I
Med Phys; 2019 May; 46(5):2512-2521. PubMed ID: 30924937
[TBL] [Abstract][Full Text] [Related]
2. Non-linear conversion of HX4 uptake for automatic segmentation of hypoxic volumes and dose prescription.
Ureba A; Lindblom E; Dasu A; Uhrdin J; Even AJG; van Elmpt W; Lambin P; Wersäll P; Toma-Dasu I
Acta Oncol; 2018 Apr; 57(4):485-490. PubMed ID: 29141489
[TBL] [Abstract][Full Text] [Related]
3. Defining the hypoxic target volume based on positron emission tomography for image guided radiotherapy - the influence of the choice of the reference region and conversion function.
Lindblom E; Dasu A; Uhrdin J; Even A; van Elmpt W; Lambin P; Wersäll P; Toma-Dasu I
Acta Oncol; 2017 Jun; 56(6):819-825. PubMed ID: 28464740
[TBL] [Abstract][Full Text] [Related]
4. High Single Doses of Radiation May Induce Elevated Levels of Hypoxia in Early-Stage Non-Small Cell Lung Cancer Tumors.
Kelada OJ; Decker RH; Nath SK; Johung KL; Zheng MQ; Huang Y; Gallezot JD; Liu C; Carson RE; Oelfke U; Carlson DJ
Int J Radiat Oncol Biol Phys; 2018 Sep; 102(1):174-183. PubMed ID: 30102194
[TBL] [Abstract][Full Text] [Related]
5. PET-based dose painting in non-small cell lung cancer: Comparing uniform dose escalation with boosting hypoxic and metabolically active sub-volumes.
Even AJ; van der Stoep J; Zegers CM; Reymen B; Troost EG; Lambin P; van Elmpt W
Radiother Oncol; 2015 Aug; 116(2):281-6. PubMed ID: 26238010
[TBL] [Abstract][Full Text] [Related]
6. Treatment fractionation for stereotactic radiotherapy of lung tumours: a modelling study of the influence of chronic and acute hypoxia on tumour control probability.
Lindblom E; Antonovic L; Dasu A; Lax I; Wersäll P; Toma-Dasu I
Radiat Oncol; 2014 Jun; 9():149. PubMed ID: 24974778
[TBL] [Abstract][Full Text] [Related]
7. Optimal fractionation in radiotherapy for non-small cell lung cancer--a modelling approach.
Lindblom E; Dasu A; Toma-Dasu I
Acta Oncol; 2015; 54(9):1592-8. PubMed ID: 26217986
[TBL] [Abstract][Full Text] [Related]
8. Phase II Study of a Radiotherapy Total Dose Increase in Hypoxic Lesions Identified by
Vera P; Thureau S; Chaumet-Riffaud P; Modzelewski R; Bohn P; Vermandel M; Hapdey S; Pallardy A; Mahé MA; Lacombe M; Boisselier P; Guillemard S; Olivier P; Beckendorf V; Salem N; Charrier N; Chajon E; Devillers A; Aide N; Danhier S; Denis F; Muratet JP; Martin E; Riedinger AB; Kolesnikov-Gauthier H; Dansin E; Massabeau C; Courbon F; Farcy Jacquet MP; Kotzki PO; Houzard C; Mornex F; Vervueren L; Paumier A; Fernandez P; Salaun M; Dubray B
J Nucl Med; 2017 Jul; 58(7):1045-1053. PubMed ID: 28254869
[TBL] [Abstract][Full Text] [Related]
9. Multiparametric imaging of patient and tumour heterogeneity in non-small-cell lung cancer: quantification of tumour hypoxia, metabolism and perfusion.
van Elmpt W; Zegers CML; Reymen B; Even AJG; Dingemans AC; Oellers M; Wildberger JE; Mottaghy FM; Das M; Troost EGC; Lambin P
Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):240-248. PubMed ID: 26338178
[TBL] [Abstract][Full Text] [Related]
10. Real-time Tumor Oxygenation Changes After Single High-dose Radiation Therapy in Orthotopic and Subcutaneous Lung Cancer in Mice: Clinical Implication for Stereotactic Ablative Radiation Therapy Schedule Optimization.
Song C; Hong BJ; Bok S; Lee CJ; Kim YE; Jeon SR; Wu HG; Lee YS; Cheon GJ; Paeng JC; Carlson DJ; Kim HJ; Ahn GO
Int J Radiat Oncol Biol Phys; 2016 Jul; 95(3):1022-1031. PubMed ID: 27130790
[TBL] [Abstract][Full Text] [Related]
11. Computed 88% TCP dose for SBRT of NSCLC from tumour hypoxia modelling.
Ruggieri R; Stavreva N; Naccarato S; Stavrev P
Phys Med Biol; 2013 Jul; 58(13):4611-20. PubMed ID: 23771131
[TBL] [Abstract][Full Text] [Related]
12. Radiobiological modeling of two stereotactic body radiotherapy schedules in patients with stage I peripheral non-small cell lung cancer.
Huang BT; Lin Z; Lin PX; Lu JY; Chen CZ
Oncotarget; 2016 Jun; 7(26):40746-40755. PubMed ID: 27203739
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of oxygenation status during fractionated radiotherapy in human nonsmall cell lung cancers using [F-18]fluoromisonidazole positron emission tomography.
Koh WJ; Bergman KS; Rasey JS; Peterson LM; Evans ML; Graham MM; Grierson JR; Lindsley KL; Lewellen TK; Krohn KA
Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):391-8. PubMed ID: 7673026
[TBL] [Abstract][Full Text] [Related]
14. Simulated dose painting of hypoxic sub-volumes in pancreatic cancer stereotactic body radiotherapy.
Elamir AM; Stanescu T; Shessel A; Tadic T; Yeung I; Letourneau D; Kim J; Lukovic J; Dawson LA; Wong R; Barry A; Brierley J; Gallinger S; Knox J; O'Kane G; Dhani N; Hosni A; Taylor E
Phys Med Biol; 2021 Sep; 66(18):. PubMed ID: 34438383
[TBL] [Abstract][Full Text] [Related]
15. Additional PET/CT in week 5-6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning?
Gillham C; Zips D; Pönisch F; Evers C; Enghardt W; Abolmaali N; Zöphel K; Appold S; Hölscher T; Steinbach J; Kotzerke J; Herrmann T; Baumann M
Radiother Oncol; 2008 Sep; 88(3):335-41. PubMed ID: 18514339
[TBL] [Abstract][Full Text] [Related]
16. A radiobiological model of reoxygenation and fractionation effects.
Guerrero M; Carlson DJ
Med Phys; 2017 May; 44(5):2002-2010. PubMed ID: 28273349
[TBL] [Abstract][Full Text] [Related]
17. A modified hypoxia-based TCP model to investigate the clinical outcome of stereotactic hypofractionated regimes for early stage non-small-cell lung cancer (NSCLC).
Strigari L; Benassi M; Sarnelli A; Polico R; D'Andrea M
Med Phys; 2012 Jul; 39(7):4502-14. PubMed ID: 22830782
[TBL] [Abstract][Full Text] [Related]
18. Tumor Control and Toxicity for Common Stereotactic Body Radiation Therapy Dose-Fractionation Regimens in Stage I Non-Small Cell Lung Cancer.
Stephans KL; Woody NM; Reddy CA; Varley M; Magnelli A; Zhuang T; Qi P; Videtic GMM
Int J Radiat Oncol Biol Phys; 2018 Feb; 100(2):462-469. PubMed ID: 29353658
[TBL] [Abstract][Full Text] [Related]
19. Investigating the potential of proton therapy for hypoxia-targeted dose escalation in non-small cell lung cancer.
Köthe A; Bizzocchi N; Safai S; Lomax AJ; Weber DC; Fattori G
Radiat Oncol; 2021 Oct; 16(1):199. PubMed ID: 34635135
[TBL] [Abstract][Full Text] [Related]
20. A clinical study of shrinking field radiation therapy based on (18)F-FDG PET/CT for stage III non-small cell lung cancer.
Ding X; Li H; Wang Z; Huang W; Li B; Zang R; Sun H; Yi Y
Technol Cancer Res Treat; 2013 Jun; 12(3):251-7. PubMed ID: 23289475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
